Your browser doesn't support javascript.
loading
Clinical and molecular characterization of novel deletions causing epsilon gamma delta beta thalassemia: Report of two cases.
Repnikova, Elena; Roberts, Jennifer; Mc Dermott, Sarah; Farooqi, Midhat S; Iqbal, Nazia Tabassum; Silvey, Michael; Nolen, Jdl; Taboada, Eugenio; Li, Weijie.
Afiliação
  • Repnikova E; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, United States.
  • Roberts J; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, United States.
  • Mc Dermott S; Hematology/ Oncology and Bone Marrow Transplant Division, Children's Mercy Hospital, Kansas City, MO, United States.
  • Farooqi MS; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, United States.
  • Iqbal NT; Hematology/ Oncology and Bone Marrow Transplant Division, Children's Mercy Hospital, Kansas City, MO, United States.
  • Silvey M; Hematology/ Oncology and Bone Marrow Transplant Division, Children's Mercy Hospital, Kansas City, MO, United States.
  • Nolen J; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, United States.
  • Taboada E; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, United States.
  • Li W; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, United States. Electronic address: wli@cmh.edu.
Pathol Res Pract ; 215(10): 152578, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31451289
Epsilon gamma delta beta (εγδß)0 - thalassemia is a very rare disorder that results from large deletions in the ß-globin gene cluster which abolish all regional globin chain gene expression from that allele. Since it is an exceedingly rare cause of neonatal anemia and is not detected by routine newborn screening, it is usually not suspected clinically and commonly undiagnosed or misdiagnosed. In this study, we describe two patients diagnosed in our hospital with (εγδß)0-thalassemia based on the results obtained from DNA microarray analysis of their peripheral blood. The first patient of mixed European descent presented as a neonate with microcytic hemolytic anemia, hyperbilirubinemia, hypoglycemia and hypothermia, and was found to have a 2.2 Mb loss that included the entire ß-globin gene cluster and the locus control region (LCR). The second patient, also of mixed European descent, presented in the neonatal period with anemia, thrombocytopenia and cutaneous extramedullary hematopoiesis, and was found to have a 59 kb loss that included the ß-globin LCR, HBE1, HBG1, and HBG2 genes. Both cases highlight the importance of recognizing the clinical features of (εγδß)0-thalassemia and implementing appropriate testing to clarify the diagnosis and manage the condition.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talassemia / Deleção de Sequência Limite: Female / Humans / Male / Newborn Idioma: En Revista: Pathol Res Pract Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talassemia / Deleção de Sequência Limite: Female / Humans / Male / Newborn Idioma: En Revista: Pathol Res Pract Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Alemanha